How Sanguine Bio is simplifying access to human biospecimens for research

I'm Chelsea, and I'm the VP of Sales for Sanguine Bio. Sanguine Bio provides human biospecimens and medical data for researchers in the diagnostic and drug development space.

Sanguine has an incredible origin story. Our founder, Brian Neman, realized that there were two really big gaps in the industry. The first was that researchers needed access to donors who they were hoping their drug was going to treat in the future, and they needed access to those fresh samples, but they didn't know how to get them. They were used to working with physicians in clinics, where it was taking incredibly long to get the samples they needed, or just having to settle for what was available off the shelf in biobanks.

On the other side of that, we knew that donors with various diseases, as well as healthy donors, were willing and motivated to participate in research. But the only method they knew to participate in research was through clinical trials, which was really invasive and a huge time commitment.

So what we started doing as a company was directly advertising to donors, letting them know that if they have a diagnosis and they're willing to provide their biospecimens, we can make it as easy as possible for them to do so, which is why Sanguine started the business.

Donors will come to our website, consent to be part of our patient community, and when they're a match for a researcher's study or need, we'll screen them, obtain consent, and send a phlebotomist to their home to collect the samples.

We offer a wide array of biospecimens that range from minimally invasive samples like blood, serum, plasma, and PBMCs, and we're also able to collect more invasive biospecimens like synovial fluid, skin punch biopsies, and cerebrospinal fluid.

Sanguine Bio is a one-stop shop for biospecimens because researchers can gain immediate access to inventory utilizing our live inventory on our website, where samples can be purchased and immediately shipped.

Or, if you're looking for something that's not available, you can meet with one of our consultants to help design a prospective study that's going to get you the samples you need.

How does Sanguine Bio’s home-based biospecimen collection model support diagnostic research and drug development?

Sanguine Bio connects researchers with consented patient and healthy donor samples through a home-based collection model. Donors join the patient community via the website, are screened and re-consented, and a phlebotomist visits their home to collect biospecimens. This donor-centric approach improves access to fresh human samples, helping accelerate diagnostic research and therapeutic development.

What types of human biospecimens does Sanguine Bio provide to researchers in the diagnostic and drug development space?

Sanguine Bio offers a wide array of human biospecimens and medical data. Minimally invasive samples include blood, serum, plasma, and PBMCs. The company also collects more invasive biospecimens such as synovial fluid, skin punch biopsies, and cerebrospinal fluid, enabling researchers to source disease-relevant samples for diagnostic and drug development studies.

How does Sanguine Bio’s live inventory and customized prospective studies improve biospecimen sourcing for researchers?

Sanguine Bio acts as a one-stop shop for biospecimens by providing live inventory access on its website, allowing researchers to purchase and immediately ship available samples. When needed samples are not in stock, Sanguine’s consultants help design customized prospective studies, ensuring efficient sourcing of specific biospecimens to advance diagnostic and therapeutic innovation.